Wockhardt Limited

NSEI:WOCKPHARMA 주식 보고서

시가총액: ₹126.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Wockhardt 관리

관리 기준 확인 4/4

Wockhardt's CEO는 Murtaza Khorakiwala, Apr2009 에 임명되었습니다 의 임기는 15.17 년입니다. 총 연간 보상은 ₹ 21.20M, 95.3% 로 구성됩니다. 95.3% 급여 및 4.7% 보너스(회사 주식 및 옵션 포함). 는 ₹ 168.38M 가치에 해당하는 회사 주식의 0.19% 직접 소유합니다. 168.38M. 경영진과 이사회의 평균 재임 기간은 각각 12.8 년과 7.6 년입니다.

주요 정보

Murtaza Khorakiwala

최고 경영자

₹21.2m

총 보상

CEO 급여 비율95.3%
CEO 임기15.3yrs
CEO 소유권0.2%
경영진 평균 재임 기간12.9yrs
이사회 평균 재임 기간7.7yrs

최근 관리 업데이트

Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Jun 22
Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Recent updates

Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Jun 30
Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Jun 22
Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation

Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%

Feb 21
Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%

There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump

Dec 19
There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump

There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues

Oct 14
There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues

Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?

Jun 23
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?

Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Feb 18
Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Jan 04
Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt

Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being

Jul 26
Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being

Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

May 18
Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)

Jan 26
Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)

What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?

Dec 01
What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?

CEO 보상 분석

Murtaza Khorakiwala 의 보수는 Wockhardt 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024₹21m₹20m

-₹5b

Dec 31 2023n/an/a

-₹5b

Sep 30 2023n/an/a

-₹5b

Jun 30 2023n/an/a

-₹6b

Mar 31 2023₹24m₹23m

-₹6b

Dec 31 2022n/an/a

-₹6b

Sep 30 2022n/an/a

-₹5b

Jun 30 2022n/an/a

-₹3b

Mar 31 2022₹24m₹17m

-₹2b

Dec 31 2021n/an/a

-₹787m

Sep 30 2021n/an/a

-₹567m

Jun 30 2021n/an/a

-₹867m

Mar 31 2021₹24m₹24m

-₹3b

Dec 31 2020n/an/a

-₹2b

Sep 30 2020n/an/a

-₹3b

Jun 30 2020n/an/a

-₹3b

Mar 31 2020₹24m₹24m

-₹2b

Dec 31 2019n/an/a

-₹1b

Sep 30 2019n/an/a

-₹2b

Jun 30 2019n/an/a

-₹2b

Mar 31 2019₹24m₹24m

-₹3b

Dec 31 2018n/an/a

-₹3b

Sep 30 2018n/an/a

-₹3b

Jun 30 2018n/an/a

-₹3b

Mar 31 2018₹24m₹19m

-₹6b

보상 대 시장: Murtaza 의 총 보상 ($USD 253.64K ) Indian 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 368.82K ).

보상과 수익: Murtaza 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Murtaza Khorakiwala (51 yo)

15.3yrs

테뉴어

₹21,200,000

보상

Dr. Murtaza Habil Khorakiwala serves as the Managing Director of Wockhardt Ltd. since April 2009 and has been its Executive Director since March 31, 2009. Dr. Khorakiwala serves as a Director of Khorakiwal...

리더십 팀

이름위치테뉴어보상소유권
Habil Khorakiwala
Founder & Executive Chairman20.4yrs₹36.50m0.39%
₹ 492.1m
Murtaza Khorakiwala
MD & Executive Director15.3yrs₹21.20m0.19%
₹ 242.3m
Huzaifa Khorakiwala
Executive Directorno data₹21.20m0.18%
₹ 231.4m
Deepak Madnani
Chief Financial Officer2.1yrs데이터 없음데이터 없음
Mahesh Patel
Chief Scientific Officer of New Drug Discoveryno data₹1.71m데이터 없음
Debolina Partap
Senior Vice President of Legalno data데이터 없음데이터 없음
Neeraj Agarwal
Chief Human Resource Officerno data데이터 없음데이터 없음
Anil Kamath
Senior Vice President of Business Developmentno data₹1.61m데이터 없음
Zoher Sihorwala
Head of Global Regulatory Affairs10.5yrs데이터 없음데이터 없음
Prakash Gupta
President of Supply Chainno data데이터 없음데이터 없음
Ravindra Limaye
Managing Director of Wockhardt UKno data데이터 없음데이터 없음
Lalit Aggarwal
President of Manufacturingno data데이터 없음데이터 없음

12.9yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 관리: WOCKPHARMA 의 관리팀은 노련하고 경험 (평균 재직 기간 12.8 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Habil Khorakiwala
Founder & Executive Chairman20.4yrs₹36.50m0.39%
₹ 492.1m
Murtaza Khorakiwala
MD & Executive Director15.3yrs₹21.20m0.19%
₹ 242.3m
Huzaifa Khorakiwala
Executive Director15.3yrs₹21.20m0.18%
₹ 231.4m
Akhilesh Krishna Gupta
Non-Executive Independent Director3.9yrs₹1.10m0.0065%
₹ 8.2m
Vinesh Jairath
Non-Executive & Independent Director7.7yrs₹1.70m데이터 없음
Zahabiya Khorakiwala
Non-Executive Non- Independent Director6.8yrs₹300.00k데이터 없음
Tasneem Vikram Mehta
Non-Executive & Independent Director9.8yrs₹1.60m데이터 없음
Ahmad Javed
Non Executive Independent Directorless than a year데이터 없음데이터 없음
Amelia Fernandes
Independent Directorless than a year₹1.00m0.000070%
₹ 88.5k

7.7yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: WOCKPHARMA 의 이사회는 경험(평균 재직 기간 7.6 년)으로 간주됩니다.